PUMCH Dementia Longitudinal Cohort Study

Chinese Academy of Medical Sciences & Peking Union Medical College

Status: Enrolling

Conditions: Dementia, Mild; Dementia, Vascular; Dementia Frontal; Dementia With Lewy Bodies; Dementia Alzheimers; Dementia; Dementia, Mixed

Study type: Observational

Funder types: Other

Identifiers

NCT05023564

PUMCH Dementia Cohort

Details and patient eligibility

About

The PUMCH Dementia Cohort is a hospital-based, observational study of Chinese elderly with cognitive impairment.

Full description

In China, the burden of dementia is increasing, which has a major impact on medical care, society, and the economy. In order to solve this important public health problem, a cohort study of cognitive impairment in the elderly should be carried out. We designed an age stratified dementia cohort and tried to to clarify the risk and prognostic factors, disease characteristics, cognitive evaluation, biomarkers, diagnosis, treatment of dementia and its subtypes in China. It is of great significance to establish a relatively comprehensive dementia database, improve the level of clinical diagnosis and treatment of cognitive impairment, and formulate prevention and treatment strategies for dementia.

Baseline data collection and cohort establishing: Detailed clinical information including demographic data, clinical history, past history and physical examination are collected. Formatted neuropsychological battery is used in all patients, including screening tests (MMSE, MoCA-PUMCH, ADL, HAD) and domain specific evaluation (Memory, executive function, visual spatial, calculation, language). Samples including serum, CSF, urine, skin, saliva are stored. Every patient is followed up every 6 months. Autopsy brain tissue will be collected if patients died.

The main contents of this study are following:

1. Explore the relationship between lifestyles, stress and dementia.
2. Assess risk factors for dementia.
3. Evaluating behavioral and psychological symptoms of dementia.
4. Improve the long-term follow-up cohort stratified by age and dementia type and construct the high standard information and sample bank.
5. Explore biomarkers of different groups of dementia, incorporating neuropsychology, multi-model neuroimaging, metabolics and proteomics based fluid biomarkers as well as genetic biomarkers. Autopsy after clinical follow up help to verify the biomarkers.
6. Establish and promote standardized and consistent biomarker detection methods.
7. Dementia education and training.
8. Use machine learning methods to establish computer-assisted dementia diagnosis system and evaluation system. Establish prediction models for the progression of dementia.

Enrollment: 20,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Neurodegenerative dementia diagnosis based on 2011 NIA-AA criteria of Dementia
• Fixed care giver and can follow up regularly

Exclusion criteria

• Not demented, including MCI
• Systemic severe diseases and severe vision or hearing problem effecting follow up and neuropsychological evaluation
• Without fixed care giver
• Reject informed consent
• Expected life shorter than 2 years

Trial design

20,000 participants in 4 patient groups

Early onset dementia

Description:

Dementia patients with onset age lower than 65y/o

Late onset dementia

Description:

Dementia patients with onset age between 65y/o and 85y/o

Oldest old dementia

Description:

Dementia patients with onset age older than 85y/o

Cognitive normal control

Description:

Normal Aging with normal cognitive function